1. Please check and comment entries here.
Table of Contents

    Topic review

    Oral Microbiome Related Diseases

    View times: 12
    Submitted by: Yeon-Hee Lee


    The human oral microbiome refers to an ecological community of symbiotic and pathogenic microorganisms found in the oral cavity. The oral cavity is an environment that provides various biological niches, such as the teeth, tongue, and oral mucosa. The oral cavity is the gateway between the external environment and the human body, maintaining oral homeostasis, protecting the mouth, and preventing disease.

    1. Introduction

    Over the past decade, various efforts have been made to identify and understand the role of the microbiome in human health and disease.With the advent of innovative genomics technologies, such as next-generation sequencing (NGS) and bioinformatic tools, which deviate from the conventional culture-based detection method, the understanding of the contribution of the human microbiome to health is deepening [1].In addition, studies on the microbiomes in and on our bodies that form a functional organ fundamental to our health and physiology are still ongoing.

    The microbiome refers to a community of microbial residents in the body.The term “microbiome” was coined by the 2001 Nobel Prize laureate Joshua Lederberg, who is credited for the Human Genome Project.The original meaning of the term is an ecosystem of symbiotic, commensal, and pathogenic microorganisms that reside in the human body [2].The oral microbiome, oral microbiota, or oral microflora are microorganisms found in the human oral cavity, constituting bacteria, fungi, eukaryotes, and viruses (Figure 1).The genome is the genetic material of an organism, the complete set of DNA, including all of its genes.In terms of the genome, the oral microbiome is defined as the collective genome of microorganisms that reside in the oral cavity.The oral microbiome reaches homeostasis with regard to this composition, which is a dynamic balance in inter-bacterial and host–bacterial interactions [3].

    Figure 1. Oral cavity and the composition of oral microbiome.

    As the oral cavity is ideal for microbiome residents, it is one of the most heavily colonized parts of the body.In addition, several distinct habitats within the oral cavity support complex and heterogeneous microbial communities.The interaction between oral microorganisms protects the human body against invasion and attack [4].Conversely, an imbalance in the oral microbiome can contribute to oral diseases such as dental caries, periodontitis, oral mucosal diseases, and/or systemic diseases [5][6].Furthermore, the relationship between the oral microbiome and the host is dynamic, and is influenced by many aspects of lifestyle, such as diet, tobacco consumption, stress, and systemic conditions, which can alter the composition and its properties and induce a state in which this finely tuned ecosystem is no longer in balance [2][7].The oral microbiome is an important link between oral and general health.

    We know that oral microbiomes are not colonized at random, but that our microbial residents have coevolved with us over millions of years.To address microbial homogeneity or divergence and maintain a harmonious state to maintain health and prevent disease, we must pay attention to our microbiomes and consider our body a superorganism.The purpose of this review is to inform oral and general healthcare practitioners on the current knowledge of the oral microbiome in health and disease, to review how molecular methods of microbial characterization have advanced our understanding, and to discuss potential implications for clinical practice.Moreover, with the recent development of technology for detecting and analyzing oral microbiomes, there is more detailed information on their existence, composition, and specific roles.For these purposes, we searched the literature via the PubMed and Google Scholar search engines, selected the top 169 articles that matched the theme for a period of 30 years prior to January 2021, and conducted an extensive and comprehensive narrative review.

    2. Factors Influencing the Oral Microbiome

    Alterations in oral microbiota composition are expected during pregnancy.During pregnancy, women undergo complex and dramatic hormonal changes that affect the composition of the oral microbiota [8].There have been reports suggesting an increased risk of periodontal disease during pregnancy and alteration of the composition of the oral microbiota [9][10][11].Porphyromonas gingivalisin periodontal pockets has been linked to microbial invasion of the amniotic cavity in association with preterm labor [12].Moreover, in a study that examined alterations in the oral microbiota between non-pregnant and pregnant states, increases in the total cultivable microbial counts and of periodontal pathogenssuch asPorphyromonas gingivalisandAggregatibacter actinomycetemcomitansduring pregnancy were observed in the gingival sulcus compared to that in non-pregnant women [13].In particular,Neisseria,Porphyromonas, andTreponemawere more abundant during pregnancy, whileStreptococcusandVeillonellawere less abundant [14].

    Antimicrobial use has also been suggested as an important factor affecting the composition of oral microbiota.Amoxicillin treatment reduced species richness and diversity and shifted the relative abundance of 35 taxa [15].They reported a substantial but incomplete recovery of the salivary microbiota composition from antibiotics approximately 3 weeks after the end of treatment.At the phylum level, the abundance ofActinobacteriawas markedly decreased by amoxicillin, which was administered for approximately 10 days.This was recovered at the level of pretreatment approximately 3 weeks after amoxicillin treatment.In comparison, the abundance ofProteobacteriain saliva was increased about 3 weeks after the amoxicillin treatment compared to the pre-treatment saliva [15].Raju et al.[16] reported the impact of antimicrobial use on saliva microbiota diversity and composition in preadolescents who systemically used amoxicillin, azithromycin amoxicillin-clavulanate, or phenoxymethylpenicillin.In addition, amoxicillin and amoxicillin-clavulanate potently decreased the abundance ofRikenellaceae.In children using azithromycin, a linear inverse association was observed between the use of azithromycin and the Shannon index [16].

    Dietary intake also influences oral microbes.For instance, frequent sugar intake increases acid production, which dissolves tooth structure and increases the risk of dental caries via the fermentation of dietary carbohydrates by oral bacteria [17].Dietary sugars and specific oral microbiota, includingTannerella forsythia,Streptococcus sobrinus, andEikenella corrodens, can have a feedforward loop in patients with dental caries [18][19].Subsequent acid production by repeated intake of high levels of carbohydrates led to sustained reductions in pH, along with the low buffering capacity of saliva.In turn, this can change the oral microbiota composition and upregulate aciduric species [20].Aciduric species, includingStreptococcus mutansandLactobacilli, which are considered to be caries-associated microbiota, also produce acid under acidic conditions [21].The change to acidic pH can lead to altered gene expression in sub-gingival bacteria, which favors the growth of pathogenic anaerobes such asP. gingivalis, which have an optimum pHfor growth of approximately 7.5 [22].Nutrition also affects periodontal bacteria and is considered a key modifiable factor for periodontitis [23].

    There is controversy regarding whether alcohol consumption is a protective factor against or a risk factor for periodontitis.However, low socioeconomic status has been associated with periodontitis [24] and dental caries [25].Alcohol consumption and socioeconomic status may also affect oral microbiome composition, considering reports on oral microbes in periodontitis and dental caries.Alterations in host immune competence can lead to an increase in the production of virulence factors, which can affect the community composition and meta-transcriptional landscape.

    3. The Oral Microbiome within Common Oral Diseases

    Epidemiologic findings revealed a more frequent occurrence of dental caries in the occlusal and proximal surfaces of the first molars [26].Pit and fissure structures or interdental spaces are anatomical factors that are protected from host defense mechanisms and avoid adequate removal of the plaque biofilm.Site-to-site variabilities in salivary film velocity and salivary clearance might affect the environmental selection and biogeography of the microbiome community, which in turn implies that the tooth surface is susceptible to demineralization [27].

    Oral cancer is a cancer of the lips, mouth, or oropharynx.In an effort to elucidate the pathogenesis of oral cancers, oral microbiota has come into the spotlight and has been suggested to be involved through three possible mechanisms [28].The chronic inflammatory responses provoked by bacteria could be responsible for this, since chronic inflammatory mediators facilitate cell proliferation, mutagenesis, and oncogene activation.

    Recent data have indicated an association between human cytomegalovirus and carcinogenesis [29].Human cytomegalovirus belongs to the beta subfamily of Herpesviridae and is frequently detected in periodontal tissues [30][31][32].Proangiogenic and anti-apoptotic mechanisms and immunosuppressive effects demonstrate the oncogenic potential of human cytomegalovirus, and a non-lytic infection of the virus can also promote the oncogenic transformation of epithelial cells [29].These data suggest that the virus may contribute to the oncogenic process of oral malignancies, although direct evidence is yet to be provided.

    More studies investigating the pathophysiology of oral cancers are required to confirm the association between oral cancer and oral microbiota; however, evidence advocating for the association is accumulating, and oral cancer surfaces harbor significantly higher numbers of oral aerobes and anaerobes compared to the healthy mucosa surface [33].Therefore, the detection and management of the oral microenvironment are essential for the control of oral malignancy.

    4. Oral Microbiome and Systemic Diseases

    Esophageal cancer has also been reported to be related toTannerella forsythiaandP. gingivalis[34].The study showed that the genusNeisseriawas associated with a lower risk of esophageal cancer, as was the carotenoid biosynthesis pathway, to which a number ofNeisseriaspecies can potentially contribute.

    Some studies have shown that periodontal diseases are associated with lung cancer risk [35][36][37]; however, it was difficult to analyze the association between oral microbiota and lung cancer because smoking, one of the biggest risk factors for lung cancer, can also affect the oral microbiota.In a small cross-sectional study, the abundance ofCapnocytophagaandVeillonellawas elevated, together with a reduced number ofNeisseria, as found by means of 16S rRNA gene sequencing [38].Thus, the current data are insufficient to conclude that oral microbial variations contribute to lung cancer.

    Significant evidence supports an association between periodontal pathogenic bacteria, preterm birth, and preeclampsia.For example,Fusobacterium nucleatumis associated with adverse pregnancy complications [39], andPorphyromonas gingivalishas been detected in the amniotic fluid of pregnant women at risk for premature delivery and in the placentas of patients with preeclampsia [12][40].

    Neurodegenerative disorders, such as Alzheimer’s disease [41] and Parkinson’s disease [42], have also been reported to be associated with the oral microbiome.The most complete study in this regard is the association betweenP. gingivalisand Alzheimer’s disease [41].P. gingivalisinfection in mice resulted in brain colonization, and gingipain proteases produced byP. gingivalishave neurotoxic characteristics.It has also been shown that typical oral species of the phylum Spirochaetes, including multiple species of the genusTreponema, often comprise amyloid plaques [43].The potential mechanisms of their action by oral taxa make this another attractive area for investigation.

    The entry is from 10.3390/diagnostics11071283


    1. Malla, M.A.; Dubey, A.; Kumar, A.; Yadav, S.; Hashem, A.; Abd Allah, E.F. Exploring the human microbiome: The potential future role of next-generation sequencing in disease diagnosis and treatment. Front. Immunol. 2019, 9, 2868.
    2. Kilian, M.; Chapple, I.L.; Hannig, M.; Marsh, P.D.; Meuric, V.; Pedersen, A.M.; Tonetti, M.S.; Wade, W.G.; Zaura, E. The oral microbiome—An update for oral healthcare professionals. Br. Dent. J. 2016, 221, 657–666.
    3. Marsh, P.D. Are dental diseases examples of ecological catastrophes? Microbiology 2003, 149, 279–294.
    4. Dewhirst, F.E.; Chen, T.; Izard, J.; Paster, B.J.; Tanner, A.C.; Yu, W.H.; Lakshmanan, A.; Wade, W.G. The human oral microbiome. J. Bacteriol. 2010, 192, 5002–5017.
    5. Gao, L.; Xu, T.; Huang, G.; Jiang, S.; Gu, Y.; Chen, F. Oral microbiomes: More and more importance in oral cavity and whole body. Protein Cell 2018, 9, 488–500.
    6. Bourgeois, D.; Inquimbert, C.; Ottolenghi, L.; Carrouel, F. Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease—Is there cause for consideration? Microorganisms 2019, 7, 424.
    7. Willis, J.R.; Gabaldón, T. The human oral microbiome in health and disease: From sequences to ecosystems. Microorganisms 2020, 8, 308.
    8. Saadaoui, M.; Singh, P.; Al Khodor, S. Oral microbiome and pregnancy: A bidirectional relationship. J. Reprod. Immunol. 2021, 145, 103293.
    9. Tettamanti, L.; Lauritano, D.; Nardone, M.; Gargari, M.; Silvestre-Rangil, J.; Gavoglio, P.; Tagliabue, A. Pregnancy and periodontal disease: Does exist a two-way relationship? ORAL Implantol. 2017, 10, 112–118.
    10. Barak, S.; Oettinger-Barak, O.; Oettinger, M.; Machtei, E.E.; Peled, M.; Ohel, G. Common oral manifestations during pregnancy: A review. Obstet. Gynecol. Surv. 2003, 58, 624–628.
    11. Madianos, P.N.; Bobetsis, Y.A.; Offenbacher, S. Adverse pregnancy outcomes (APOs) and periodontal disease: Pathogenic mechanisms. J. Periodontol. 2013, 84, S170–S180.
    12. León, R.; Silva, N.; Ovalle, A.; Chaparro, A.; Ahumada, A.; Gajardo, M.; Martinez, M.; Gamonal, J. Detection of porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J. Periodontol. 2007, 78, 1249–1255.
    13. Fujiwara, N.; Tsuruda, K.; Iwamoto, Y.; Kato, F.; Odaki, T.; Yamane, N.; Hori, Y.; Harashima, Y.; Sakoda, A.; Tagaya, A.; et al. Significant increase of oral bacteria in the early pregnancy period in Japanese women. J. Investig. Clin. Dent. 2017, 8, e12189.
    14. Lin, W.; Jiang, W.; Hu, X.; Gao, L.; Ai, D.; Pan, H.; Niu, C.; Yuan, K.; Zhou, X.; Xu, C.; et al. Ecological shifts of supragingival microbiota in association with pregnancy. Front. Cell. Infect. Microbiol. 2018, 8, 24.
    15. Lazarevic, V.; Manzano, S.; Gaïa, N.; Girard, M.; Whiteson, K.; Hibbs, J.; François, P.; Gervaix, A.; Schrenzel, J. Effects of amoxicillin treatment on the salivary microbiota in children with acute otitis media. Clin. Microbiol. Infect. 2013, 19, e335–e342.
    16. Raju, S.C.; Viljakainen, H.; Figueiredo, R.A.O.; Neuvonen, P.J.; Eriksson, J.G.; Weiderpass, E.; Rounge, T.B. Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition. Microbiome 2020, 8, 121.
    17. Gupta, P.; Gupta, N.; Pawar, A.P.; Birajdar, S.S.; Natt, A.S.; Singh, H.P. Role of sugar and sugar substitutes in dental caries: A review. ISRN Dent. 2013, 2013, 519421.
    18. Inquimbert, C.; Bourgeois, D.; Bravo, M.; Viennot, S.; Tramini, P.; Llodra, J.C.; Molinari, N.; Dussart, C.; Giraudeau, N.; Carrouel, F. The oral bacterial microbiome of interdental surfaces in adolescents according to carious risk. Microorganisms 2019, 7, 319.
    19. Lamont, R.J.; Koo, H.; Hajishengallis, G. The oral microbiota: Dynamic communities and host interactions. Nat. Rev. Microbiol. 2018, 16, 745–759.
    20. Takahashi, N.; Nyvad, B. The role of bacteria in the caries process: Ecological perspectives. J. Dent. Res. 2011, 90, 294–303.
    21. Gross, E.L.; Leys, E.J.; Gasparovich, S.R.; Firestone, N.D.; Schwartzbaum, J.A.; Janies, D.A.; Asnani, K.; Griffen, A.L. Bacterial 16S sequence analysis of severe caries in young permanent teeth. J. Clin. Microbiol. 2010, 48, 4121–4128.
    22. Faran Ali, S.M.; Tanwir, F. Oral microbial habitat a dynamic entity. J. Oral Biol. Craniofac. Res. 2012, 2, 181–187.
    23. Martinon, P.; Fraticelli, L.; Giboreau, A.; Dussart, C.; Bourgeois, D.; Carrouel, F. Nutrition as a key modifiable factor for periodontitis and main chronic diseases. J. Clin. Med. 2021, 10, 197.
    24. Han, S.J.; Bae, K.H.; Lee, H.J.; Kim, S.J.; Cho, H.J. Association between regular walking and periodontitis according to socioeconomic status: A cross-sectional study. Sci. Rep. 2019, 9, 12969.
    25. Schwendicke, F.; Dörfer, C.E.; Schlattmann, P.; Foster Page, L.; Thomson, W.M.; Paris, S. Socioeconomic inequality and caries: A systematic review and meta-analysis. J. Dent. Res. 2015, 94, 10–18.
    26. Hopcraft, M.S.; Morgan, M.V. Pattern of dental caries experience on tooth surfaces in an adult population. Community Dent. Oral. Epidemiol. 2006, 34, 174–183.
    27. Almståhl, A.; Carlén, A.; Eliasson, L.; Lingström, P. Lactobacillus species in supragingival plaque in subjects with hyposalivation. Arch. Oral. Biol. 2010, 55, 255–259.
    28. Zhang, Y.; Wang, X.; Li, H.; Ni, C.; Du, Z.; Yan, F. Human oral microbiota and its modulation for oral health. Biomed. Pharmacother. 2018, 99, 883–893.
    29. Naucler, C.S.; Geisler, J.; Vetvik, K. The emerging role of human cytomegalovirus infection in human carcinogenesis: A review of current evidence and potential therapeutic implications. Oncotarget 2019, 10, 4333–4347.
    30. Foglio-Bonda, P.L.; Gabriele, M.; Graziani, F.; De Andrea, M.; Mondini, M.; Gariglio, M. High prevalence of human cytomegalovirus in a population of periodontally healthy subjects. Med. Oral Patol. Oral Cir. Bucal. 2010, 15, e292–e296.
    31. Saboia-Dantas, C.J.; Coutrin de Toledo, L.F.; Sampaio-Filho, H.R.; Siqueira, J.F., Jr. Herpesviruses in asymptomatic apical periodontitis lesions: An immunohistochemical approach. Oral Microbiol. Immunol. 2007, 22, 320–325.
    32. Sunde, P.T.; Olsen, I.; Enersen, M.; Beiske, K.; Grinde, B. Human cytomegalovirus and Epstein-Barr virus in apical and marginal periodontitis: A role in pathology? J. Med. Virol. 2008, 80, 1007–1011.
    33. Nagy, K.N.; Sonkodi, I.; Szoke, I.; Nagy, E.; Newman, H.N. The microflora associated with human oral carcinomas. Oral Oncol. 1998, 34, 304–308.
    34. Peters, B.A.; Wu, J.; Pei, Z.; Yang, L.; Purdue, M.P.; Freedman, N.D.; Jacobs, E.J.; Gapstur, S.M.; Hayes, R.B.; Ahn, J. Oral microbiome composition reflects prospective risk for esophageal cancers. Cancer Res. 2017, 77, 6777–6787.
    35. Michaud, D.S.; Liu, Y.; Meyer, M.; Giovannucci, E.; Joshipura, K. Periodontal disease, tooth loss, and cancer risk in male health professionals: A prospective cohort study. Lancet Oncol. 2008, 9, 550–558.
    36. Vogtmann, E.; Goedert, J.J. Epidemiologic studies of the human microbiome and cancer. Br. J. Cancer 2016, 114, 237–242.
    37. Zeng, X.T.; Xia, L.Y.; Zhang, Y.G.; Li, S.; Leng, W.D.; Kwong, J.S. Periodontal disease and incident lung cancer risk: A meta-analysis of cohort studies. J. Periodontol. 2016, 87, 1158–1164.
    38. Yan, X.; Yang, M.; Liu, J.; Gao, R.; Hu, J.; Li, J.; Zhang, L.; Shi, Y.; Guo, H.; Cheng, J. Discovery and validation of potential bacterial biomarkers for lung cancer. Am. J. Cancer Res. 2015, 5, 3111.
    39. Han, Y.W.; Fardini, Y.; Chen, C.; Iacampo, K.G.; Peraino, V.A.; Shamonki, J.M.; Redline, R.W. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet. Gynecol. 2010, 115, 442.
    40. Katz, J.; Chegini, N.; Shiverick, K.; Lamont, R. Localization of P. gingivalis in preterm delivery placenta. J. Dent. Res. 2009, 88, 575–578.
    41. Dominy, S.S.; Lynch, C.; Ermini, F.; Benedyk, M.; Marczyk, A.; Konradi, A.; Nguyen, M.; Haditsch, U.; Raha, D.; Griffin, C. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci. Adv. 2019, 5, eaau3333.
    42. Mihaila, D.; Donegan, J.; Barns, S.; LaRocca, D.; Du, Q.; Zheng, D.; Vidal, M.; Neville, C.; Uhlig, R.; Middleton, F.A. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLoS ONE 2019, 14, e0218252.
    43. Miklossy, J. Bacterial amyloid and DNA are important constituents of senile plaques: Further evidence of the spirochetal and biofilm nature of senile plaques. J. Alzheimer Dis. 2016, 53, 1459–1473.